Skip to main content

ImaGenes Named Agilent Service Provider

NEW YORK (GenomeWeb News) – German microarray services firm imagines said today that it has been named an Agilent Technologies Certified Services Provider for expression profiling services.
 
The Berlin-based firm said that the CSP status involves the application of the entire Agilent microarray workflow, from quality controls to reagents, data extraction, and analysis software with the Genespring DX platform.
 
“We anticipate synergy between the Agilent microarray platform and imaGenes’ next generation sequencing service, bioinformatics offerings, and corresponding clone resources,” Chris Grimley, Agilent’s senior marketing director for genomics, said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.